"The agency hasn’t focused much on tobacco control since former commissioner Scott Gottlieb left in 2019. Critics say that without a committed leader, the Center for tobacco Products [CTP] has been directionless — frustrating for both industry and public health officials.
“FDA’s been a bit of a piñata really since Gottlieb left, so they’ve kind of left it to the career staff there to figure out priorities,” said a senior tobacco industry official with experience of CTP reviews who requested anonymity due to the agency’s ongoing review of their products. “They’ve just gotten battered by everybody.”
The overlooked public health issue that could make or break Biden’s new drug regulator
Many Believe that the CTP shouldn't be under the FDA's control. That the Only Way to get any Meaningful Tobacco and Scientific Based THR Policy is to make the CTP a Separate, Autonomous Agency.
A head it by someone else besides Zeller.
“FDA’s been a bit of a piñata really since Gottlieb left, so they’ve kind of left it to the career staff there to figure out priorities,” said a senior tobacco industry official with experience of CTP reviews who requested anonymity due to the agency’s ongoing review of their products. “They’ve just gotten battered by everybody.”
The overlooked public health issue that could make or break Biden’s new drug regulator
Many Believe that the CTP shouldn't be under the FDA's control. That the Only Way to get any Meaningful Tobacco and Scientific Based THR Policy is to make the CTP a Separate, Autonomous Agency.
A head it by someone else besides Zeller.